European and Developing Countries Clinical Trials Partnership

[4][permanent dead link‍] The Programme was to be based on three central pillars: "the impact of existing interventions, the affordability of key pharmaceuticals and trade, and the research and development of specific global public goods.

[6] EDCTP-funded activities are based on: Partnerships among the EU and associated countries, allowing focused collaboration of national and European efforts that were not previously coordinated.

Acceleration of the development of new or improved drugs, vaccines and microbicides against HIV/AIDS, malaria and tuberculosis, with a focus on phase II and III clinical trials in sub-Saharan Africa.

The Partnership is intended to be a long-term initiative (10–20 years) and a separate legal entity has been created to maintain its independence and flexibility.

[citation needed] Taken together, clinical trials based in developing countries where the diseases are endemic, capacity building, and South-South networking are expected to make up over 90% of the overall budget.